Literature DB >> 10837737

Liposomes for scintigraphic detection of infection and inflammation.

.   

Abstract

Liposomes are small vesicles consisting of one or more concentric lipid bilayers enclosing discrete aqueous spaces. Liposomes potentially serve as carriers for radiolabels to visualize pathological processes scintigraphically. Research performed during the last two decades has revealed insight on the characteristics of liposomes with regard to their tissue distribution after i.v. injection. Various approaches have been developed to radiolabel liposomes with gamma-emitting radionuclides such as Ga-67, In-111 and Tc-99m. Preferably, liposomes are labeled according to the 'after-loading' method. The radionuclide can either be encapsulated in the aqueous interior or coupled to the lipid bilayer. The potential of radiolabeled liposomes to image infectious and inflammatory foci has been demonstrated in a variety of preclinical studies. Recently, a study in patients suspected of having infectious or inflammatory disease has been initiated. Preliminary clinically results exemplify the potential of Tc-99m-PEG liposomes to image infection and inflammation.

Entities:  

Year:  1999        PMID: 10837737     DOI: 10.1016/s0169-409x(98)00095-7

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  11 in total

Review 1.  [Current insights into the development of new glucocorticoid receptor ligands].

Authors:  F Buttgereit; I-H Song; R H Straub; G-R Burmester
Journal:  Z Rheumatol       Date:  2005-04       Impact factor: 1.372

Review 2.  Nanosystems for simultaneous imaging and drug delivery to T cells.

Authors:  Tarek M Fahmy; Peter M Fong; Jason Park; Todd Constable; W Mark Saltzman
Journal:  AAPS J       Date:  2007-06-08       Impact factor: 4.009

3.  Liposomal targeting of glucocorticoids to synovial lining cells strongly increases therapeutic benefit in collagen type II arthritis.

Authors:  J M Metselaar; W B van den Berg; A E M Holthuysen; M H M Wauben; G Storm; P L E M van Lent
Journal:  Ann Rheum Dis       Date:  2004-04       Impact factor: 19.103

Review 4.  The use of lipid-based nanocarriers for targeted pain therapies.

Authors:  Susan Hua; Sherry Y Wu
Journal:  Front Pharmacol       Date:  2013-11-21       Impact factor: 5.810

Review 5.  Polymer therapeutics in surgery: the next frontier.

Authors:  Ernest A Azzopardi; R Steven Conlan; Iain S Whitaker
Journal:  J Interdiscip Nanomed       Date:  2016-04-18

6.  Improvement of pyrazolo[3,4-d]pyrimidines pharmacokinetic properties: nanosystem approaches for drug delivery.

Authors:  Giulia Vignaroli; Pierpaolo Calandro; Claudio Zamperini; Federica Coniglio; Giulia Iovenitti; Matteo Tavanti; David Colecchia; Elena Dreassi; Massimo Valoti; Silvia Schenone; Mario Chiariello; Maurizio Botta
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

Review 7.  Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine.

Authors:  Francis Man; Peter J Gawne; Rafael T M de Rosales
Journal:  Adv Drug Deliv Rev       Date:  2019-06-03       Impact factor: 15.470

8.  Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis.

Authors:  Maiara Maria Romanelli; Thais Alves da Costa-Silva; Edezio Cunha-Junior; Daiane Dias Ferreira; Juliana M Guerra; Andres Jimenez Galisteo; Erika Gracielle Pinto; Leandro R S Barbosa; Eduardo Caio Torres-Santos; Andre Gustavo Tempone
Journal:  Front Cell Infect Microbiol       Date:  2019-10-29       Impact factor: 5.293

Review 9.  Advances and Challenges of Liposome Assisted Drug Delivery.

Authors:  Lisa Sercombe; Tejaswi Veerati; Fatemeh Moheimani; Sherry Y Wu; Anil K Sood; Susan Hua
Journal:  Front Pharmacol       Date:  2015-12-01       Impact factor: 5.810

Review 10.  Targeting sites of inflammation: intercellular adhesion molecule-1 as a target for novel inflammatory therapies.

Authors:  Susan Hua
Journal:  Front Pharmacol       Date:  2013-10-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.